Titécat Marie, Senneville Eric, Wallet Frédéric, Dezèque Hervé, Migaud Henri, Courcol René J, Loïez Caroline
1 Institute of Microbiology, University Hospital Center , Lille, France .
Surg Infect (Larchmt). 2015 Feb;16(1):77-83. doi: 10.1089/sur.2013.258. Epub 2015 Feb 4.
Staphylococci, especially coagulase-negative staphylococci (CoNS) represent the most frequent micro-organism associated with osteoarticular infections (OAIs), especially those involving orthopedic devices. The antibiotic susceptibility profile of the bacteria mostly responsible for OAIs is therefore crucial information for choosing the appropriate antibiotic regimen administered during the removal procedure until the first results of the conventional culture.
The antibiotic susceptibility profile of staphylococci isolated from OAIs in a referent center for osteoarticular infection was studied over a 10-y period to adapt antibiotic protocols to the ecology.
From 2002 to 2011, the resistance of Staphylococcus aureus to methicillin and rifampicin decreased (27.9% versus 20.6% and 13% versus 1%, respectively); the resistance to fluoroquinolones (FQ) was stable (24% on average), and all the isolates were susceptible to glycopeptides. For CoNS, the resistance to methicillin, rifampicin, and FQ increased (30.4% versus 43.9%, 13% versus 18.5%, and 20.3% versus 34.1%, respectively) over the same period. Resistance of the CoNS to vancomycin was observed in 2011 for the first time (2.3%), and 3.8% were resistant to teicoplanin in 2002 compared with 22% in 2011, with 3.5% resistant to linezolid in 2011.
The sensibility of bacteria over 10 y remained stable, except for CoNS. The increase of the resistances for CoNS led us to exclude teicoplanin from the first-line empiric antibiotic treatment, to avoid linezolid, and to prefer vancomycin or daptomycin.
葡萄球菌,尤其是凝固酶阴性葡萄球菌(CoNS)是与骨关节炎感染(OAI)相关的最常见微生物,特别是那些涉及骨科器械的感染。因此,对导致OAI的主要细菌的抗生素敏感性分析是选择在取出手术过程中直至传统培养的初步结果出来之前使用的合适抗生素方案的关键信息。
在一个骨关节炎感染参考中心,对10年间从OAI中分离出的葡萄球菌的抗生素敏感性进行了研究,并根据生态学情况调整抗生素方案。
2002年至2011年期间,金黄色葡萄球菌对甲氧西林和利福平的耐药性下降(分别从27.9%降至20.6%以及从13%降至1%);对氟喹诺酮类(FQ)的耐药性保持稳定(平均为24%),并且所有分离株对糖肽类敏感。对于CoNS,同期对甲氧西林、利福平及FQ的耐药性均有所增加(分别从30.4%升至43.9%、从13%升至18.5%以及从20.3%升至34.1%)。2011年首次观察到CoNS对万古霉素耐药(2.3%),2002年有3.8%对替考拉宁耐药,而2011年为22%;2011年有3.5%对利奈唑胺耐药。
除CoNS外,10年间细菌的敏感性保持稳定。CoNS耐药性的增加使我们将替考拉宁排除在一线经验性抗生素治疗之外,并避免使用利奈唑胺,优先选择万古霉素或达托霉素。